Navigation Links
FASEB President Addresses Congressional Audience at Coalition for Health Funding Briefing on Public Health
Date:3/2/2010

BETHESDA, Md., March 2 /PRNewswire-USNewswire/ -- Federation of American Societies for Experimental Biology (FASEB) President Mark O. Lively, Ph.D., addressed a Capitol Hill audience, including congressional staff, and members of the Coalition for Health Funding (CHF) today to describe the critical role biomedical research plays in improving public health. "At a time when our nation is searching for ways to repair and improve our troubled healthcare system, I am here to reemphasize the importance of providing steady and sustained funding for biomedical research in the United States," Lively stated during the CHF-organized event titled, Public Health 101: Building Capacity to Meet America's Mounting Health Needs.

Lively pointed out the drastic toll chronic disease takes on both health care spending and the lives of patients suffering from these conditions. "But the good news," he added, "is that biomedical research has contributed significantly to improved health and the opportunities for continued progress have never been brighter." Lively acknowledged the challenge presented by the country's current economic situation, but reiterated the value of our investment in the National Institutes of Health (NIH). "Now is not the time to pull back from our historic commitment to investigation and discovery," he said. "Fundamental scientific discoveries funded by NIH form the basis for the ongoing transformation of the practice of medicine." He went on to list a number of NIH's recent accomplishments in advancing medicine and health, including dramatic reductions in deaths from heart disease and cancer and development of a host of new drug therapies.

In concluding, Lively highlighted the future promise of an accelerated pace of discovery. "We are at the beginning of a whole new era of pharmacogenomics that will identify ways to tailor treatments and scientifically match therapies to individuals," he declared, describing how advances in genomic sequencing have already led to the dawn of personalized medicine. "Continued progress towards that goal depends on sustained and predictable funding support for NIH... one critical part of the prescription for improved health. Research means hope."

For the full transcript of Lively's remarks, please see: http://opa1.faseb.org/pages/LG/livelyCHFspeech.htm

FASEB is composed of 23 societies with more than 90,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improve -- through their research -- the health, well-being and productivity of all people. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.

SOURCE Federation of American Societies for Experimental Biology

Back to top

RELATED LINKS
http://www.faseb.org

'/>"/>

SOURCE Federation of American Societies for Experimental Biology
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Amira Pharmaceuticals to Present Preclinical Data from LPA1 Receptor Antagonist Program at FASEB Summer Research Conference
2. President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors
3. Landrieu Comments on Presidents Small Business Health Care Report
4. DNC Chairman Tim Kaine Applauds President, Members of Congress on Todays Bipartisan Summit
5. DNC Hispanic Caucus Chairwoman Praises President Obamas Leadership on Bipartisan Health Reform Summit
6. AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on Inside Government Radio Show
7. Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum
8. LocumTenens.com Names Lisa Kaeck Executive Vice President
9. Sensaria Names Kathy Bintz-Fertitta as New President
10. Comments by American Dental Association President Dr. Ron Tankersley on the Pew Center on the States report The Cost of Delay: State Dental Policies Fail One in Five Children
11. Ricochet PR Names Valerie Carter Vice President of Washington, D.C. Public Affairs Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... ... As a leading dental practice, Wall Centre Dental supports Stroke Awareness Month ... bleeding gums in Vancouver, BC, may be developing gingivitis, the first stage of ... and diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer laser gum therapy ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage ... featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA Flex ... cotton easy care stretch twill. , With trendy looks hitting the medical community, UA ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ... world’s water crisis and how it affects the human eyes. , According ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. ... focused on the design, manufacture, sale and distribution of ... on the progress of its commercial roll-out in ... available in more than one hundred (100) medical institutions ... AeroForm offers a needle-free alternative for women who ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: